Spleen News and Research

RSS
Experimental drug PKC412 may be the key to treating myeloproliferative disease

Experimental drug PKC412 may be the key to treating myeloproliferative disease

Cancer drug may reduce kidney disease in lupus

Cancer drug may reduce kidney disease in lupus

WHO tackles the parasitic disease Leishmaniasis in Afghanistan

WHO tackles the parasitic disease Leishmaniasis in Afghanistan

Discovery could pave the way to smallpox Immunity

Discovery could pave the way to smallpox Immunity

Cigarette smoking linked to leukemia

Cigarette smoking linked to leukemia

Link between oral bacterium and premature babies

Link between oral bacterium and premature babies

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Extended lymph node dissection fails to increase survival among gastric cancer patients

Extended lymph node dissection fails to increase survival among gastric cancer patients

Extended lymph node dissection, a treatment for gastric cancer

Extended lymph node dissection, a treatment for gastric cancer

Researchers find new purpose for existing drugs to suppress colon cancer metastasis, secure post-radiation brain function, and trick tumors

Researchers find new purpose for existing drugs to suppress colon cancer metastasis, secure post-radiation brain function, and trick tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.